Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/1997
12/02/1997US5693506 Isolated dna sequence comprising transcriptional initiation region obtained from specified nucleic acid sequence
12/02/1997US5693504 Microorganism resistant to nicotinic acid analogue and production of biotin
12/02/1997US5693502 Nucleic acid ligand inhibitors to DNA polymerases
12/02/1997US5693499 Plasmid comprising promoter dna, dna coding signal peptide, dna coding coagulation factor viii amino acid sequences, and termination codon; gene expression
12/02/1997US5693498 DNA encoding a plerocerciod growth factor
12/02/1997US5693497 Incubation of genetically engineered cells for gene expression of antigen which can be used for vaccines or diagnosis
12/02/1997US5693496 DNA encoding the mouse and human PH30 beta chain protein
12/02/1997US5693495 Allergens of alder pollen and applications thereof
12/02/1997US5693493 Modular assembly of antibody genes, antibodies prepared thereby and use
12/02/1997US5693492 Purified dna molecule encoding drosophila avermectin and/or glutamate binding protein which functions as glutamate-gated anion channel
12/02/1997US5693491 Isolated and purified polynucleotide comprising nucleotide sequence encoding receptor having specified amino acid sequence
12/02/1997US5693490 Production of glycolate oxidase in methylotrophic yeast
12/02/1997US5693489 Cloning and expression of the gene for bacteriophage T7 RNA polymerase
12/02/1997US5693487 Diagnostic or prognostic indicator for diverse types of cancer determined by changes in the levels of max:myc complex that binds to nucleotide sequences comprising cacgtg
12/02/1997US5693486 Microbiocides against escherichia, listeria, candida; contact lens antiseptic
12/02/1997US5693478 Method of detecting amyloid precursor proteins
12/02/1997US5693473 Linked breast and ovarian cancer susceptibility gene
12/02/1997US5693472 Detecting dna of seq id no:1,2,3 or 4 by hybridization probing and/or nucleotide sequence amplification; testing samples of surface water or feces; vaccines
12/02/1997US5693471 Triple stranded nucleic acids
12/02/1997US5693466 Quantitative analyzing by radiography; solvent extraction the sampling, immobilizing on membrane and with labeled oligonucleotide
12/02/1997US5693464 Providing library of dna sequences including region of interest, linking defined oligonucleotide sequence to each, hybridizing to chromosomal dna in situ, microdissecting, amplifying using oligonucleotide sequence as primer
12/02/1997US5693463 Measuring amount of protein bound to double-stranded dna test oligonucleotide before and after incubation, repeating with different test sequences, comparison for rank order
11/1997
11/30/1997CA2206625A1 Cytoplasmic male sterile brassica oleracea plant, and method for obtaining such plant
11/29/1997CA2187728A1 Iron-regulated metal transporters and uses therefor
11/27/1997WO1997044668A1 Early detection of lysosomal storage disorders
11/27/1997WO1997044656A1 Compositions and methods for modulating type i interleukin-1 receptor expression
11/27/1997WO1997044492A1 Treatment of hiv infection by interfering with host topoisomerase interaction with hiv gag and rt
11/27/1997WO1997044491A1 Methods of detection utilizing modified bacteriophage
11/27/1997WO1997044488A2 Compositions and methods for the detection of mycobacterium kansasii
11/27/1997WO1997044486A1 Identification of target bacteria by fluorescence detection of primer directed amplification products
11/27/1997WO1997044485A1 Methods for identifying a mutation in a gene of interest
11/27/1997WO1997044481A1 Compositions and methods for screening antimicrobials
11/27/1997WO1997044475A1 Adenovirus vectors for gene therapy
11/27/1997WO1997044474A2 Viral particles which are masked or unmasked with respect to a cell receptor
11/27/1997WO1997044473A1 Methods for producing and transforming cassave protoplasts
11/27/1997WO1997044472A1 Nucleic acid molecules coding soluble maize starch synthases
11/27/1997WO1997044471A2 Potato plants with reduced cytosolic starch phosphorylasis and modified germination
11/27/1997WO1997044470A1 Novel yeast promoters suitable for expression cloning in yeast and heterologous expression of proteins in yeast
11/27/1997WO1997044469A2 Multiple epitope fusion protein
11/27/1997WO1997044468A1 HUMAN INTERLEUKIN-1j AND ANTAGONISTS THEREOF
11/27/1997WO1997044467A1 MITOGEN-ACTIVATED PROTEIN KINASE p38-2 AND METHODS OF USE THEREFOR
11/27/1997WO1997044466A1 Characterization and use of an isolated uridine diphospho-glucuronosyltransferase
11/27/1997WO1997044465A1 Method for controlling seed germination using soybean acyl coa oxidase sequences
11/27/1997WO1997044464A1 Helicobacter pylori acid inhibitory factor 1
11/27/1997WO1997044463A2 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin
11/27/1997WO1997044462A1 Use of chemokine antagonist molecules for their antiviral activity, particularly against an hiv type retrovirus
11/27/1997WO1997044461A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
11/27/1997WO1997044460A1 Modulators of tissue regeneration
11/27/1997WO1997044459A1 Gamma ii adaptin
11/27/1997WO1997044458A1 Kappa/mu-like protein tyrosine phosphatase, ptp lambda
11/27/1997WO1997044457A1 Polycystic kidney disease gene
11/27/1997WO1997044456A2 Tumor virus susceptibility genes and gene products, and uses related thereto
11/27/1997WO1997044455A1 Hematopoietic cytokine receptor
11/27/1997WO1997044454A2 Human phospholipase inhibitor
11/27/1997WO1997044453A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
11/27/1997WO1997044452A1 Human b-cell antigens, related reagents
11/27/1997WO1997044451A2 Vasoactive amine binding molecules
11/27/1997WO1997044450A1 Regulation of gene expression
11/27/1997WO1997044449A1 Promoters for swine complement inhibitors
11/27/1997WO1997044448A1 Promoter elements conferring root-preferred gene expression
11/27/1997WO1997044447A2 Transcriptional activation system, activators, and uses therefor
11/27/1997WO1997044446A1 Dna vaccines for eliciting a mucosal immune response
11/27/1997WO1997044444A1 Immortalized avian cell lines
11/27/1997WO1997044443A1 Immortal avian cells
11/27/1997WO1997044441A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
11/27/1997WO1997044440A1 Cell line
11/27/1997WO1997044439A2 Method of producing doxorubicin
11/27/1997WO1997044362A1 MUTATED NONACTIVATING IgG2 DOMAINS AND ANTI-CD3 ANTIBODIES INCORPORATING THE SAME
11/27/1997WO1997044361A1 Endoglucanases
11/27/1997WO1997044360A1 Novel human g-protein coupled receptor
11/27/1997WO1997044359A1 Novel human g-protein coupled receptor
11/27/1997WO1997044357A1 Synthetic glucagon binding proteins
11/27/1997WO1997044356A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH
11/27/1997WO1997044352A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/27/1997WO1997044348A1 Ribozyme-mediated gene replacement
11/27/1997WO1997044346A2 Specific inhibitors of dna methyltransferase enzyme
11/27/1997WO1997044345A1 Nucleoside derivatives with photo-unstable protective groups
11/27/1997WO1997044134A1 Jet droplet device and method
11/27/1997WO1997044058A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same
11/27/1997WO1997044055A1 Methods of identifying g-coupled receptors associated with macrophage-trophic hiv, and diagnostic and therapeutic uses thereof
11/27/1997WO1997044052A1 Immunomodulating compounds comprising d-isomers of amino acids
11/27/1997WO1997044046A1 Platelet-derived growth factor expression inhibitor
11/27/1997WO1997043901A1 IceA GENE AND RELATED METHODS
11/27/1997WO1997040170A3 Functional expression of heterologous adenylyl cyclase
11/27/1997WO1997039102A3 Secreted proteins
11/27/1997WO1997037039A3 Use of extremely thermophilic dna-polymerases
11/27/1997WO1997035976A3 Epidermal differentiation factor
11/27/1997WO1997035476A3 Use of aromatic aldehydes as insecticides and for killing arachnids
11/27/1997WO1997031111A3 A family of organic anion transporters, nucleic acids encoding them, cells comprising them and methods for using them
11/27/1997WO1997031107A3 Human serum lectin - induced apoptosis and method for detecting apoptosis
11/27/1997WO1997030177A3 Process for recognizing the risk of becoming ill after an arthropod bite
11/27/1997WO1997020937A3 Modification process
11/27/1997DE19629938C1 Monoclonal antibodies specific for mutated E-Cadherin peptide sequences
11/27/1997DE19620804A1 Cassette for expressing storage-stable proteins in plants
11/27/1997DE19620170A1 Nucleosid-Derivate mit photolabilen Schutzgruppen Nucleoside derivatives with photolabile protecting groups
11/27/1997CA2804657A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
11/27/1997CA2731490A1 Early detection of lysosomal storage disorders
11/27/1997CA2496906A1 Ret ligand (retl) for stimulating neural and renal growth
11/27/1997CA2258698A1 Immunomodulating compounds comprising d-isomers of amino acids
11/27/1997CA2256589A1 Treatment of hiv infection by interfering with host topoisomerase interaction with hiv gag and rt
1 ... 3578 3579 3580 3581 3582 3583 3584 3585 3586 3587 3588 3589 3590 3591 3592 3593 3594 3595 3596 3597 3598 ... 4023